CD (Suzhou) Biopharma Co., Ltd.
PrivateLast Round
Series A
May 1, 2023
Company Overview
CD (Suzhou) Biopharma Co., Ltd. operates in Healthcare & Life Sciences and is based in Suzhou. Its latest recorded funding round was an Angel round in June 2022.
CD (Suzhou) Biopharma Co., Ltd. is a biotechnology company that develops innovative immunotherapies for oncology, viral infections, and autoimmune diseases using its proprietary Bispecific Fusion Protein (BsFP) platform and IMmune-Enhanced (IME) cell technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CD (Suzhou) Biopharma Co., Ltd. Comparables
Compare CD (Suzhou) Biopharma Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Innovent Biologics | 82% | |
| Anwita Biosciences Inc. | 81% | |
| EpimAb Biotherapeutics | 77% |
For institutional investors. Book with your work email.
CD (Suzhou) Biopharma Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 1, 2023 | ||||
| Angel | Jun 29, 2022 |
For institutional investors. Book with your work email.
CD (Suzhou) Biopharma Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Proxima Ventures Ltd. | Angel |
| BioHub | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2023
Completed a Series A funding round.
- Jun 29, 2022
Proxima Ventures Ltd. led the funding round.
For institutional investors. Book with your work email.
CD (Suzhou) Biopharma Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about CD (Suzhou) Biopharma Co., Ltd.'s valuation, stock price, and market status.
Is CD (Suzhou) Biopharma Co., Ltd. a public or private company?
CD (Suzhou) Biopharma Co., Ltd. is a private company.
What is the current stock price of CD (Suzhou) Biopharma Co., Ltd.?
CD (Suzhou) Biopharma Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks CD (Suzhou) Biopharma Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is CD (Suzhou) Biopharma Co., Ltd. worth (valuation)?
Valuation information for CD (Suzhou) Biopharma Co., Ltd. is not publicly available.
Can I buy CD (Suzhou) Biopharma Co., Ltd. stock?
CD (Suzhou) Biopharma Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was CD (Suzhou) Biopharma Co., Ltd.'s last funding round?
CD (Suzhou) Biopharma Co., Ltd.'s most recent funding round was Series A on May 1, 2023.
Who are the main investors in CD (Suzhou) Biopharma Co., Ltd.?
Key investors in CD (Suzhou) Biopharma Co., Ltd. include Proxima Ventures Ltd., BioHub.
Will CD (Suzhou) Biopharma Co., Ltd. IPO soon?
No public IPO plans have been announced for CD (Suzhou) Biopharma Co., Ltd..
How can I track CD (Suzhou) Biopharma Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in CD (Suzhou) Biopharma Co., Ltd.'s shares on secondary markets.